Human factor VIII:C purified using monoclonal antibody to von Willebrand factor
Levine, P.H.
Seminars in Hematology 25(2 Suppl 1: 1-2
1988
ISSN/ISBN: 0037-1963 PMID: 3133770 Document Number: 324323
Document emailed within 1 workday
Related Documents
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274Kasper, C.K.; Kim, H.C.; Gomperts, E.D.; Smith, K.J.; Salzman, P.M.; Tipping, D.; Miller, R.; Montgomery, R.M. 1991: In vivo recovery and survival of monoclonal-antibody-purified factor VIII concentrates Thrombosis and Haemostasis 66(6): 730-733
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Davis, H.M.; Brown, S.K.; Nash, D.W.; Pennetti, A.M.; Salzman, P.M.; Schreiber, A.B.; Haimovich, J. 1990: Lack of immune response to mouse IgG in hemophilia a patients treated chronically with Monoclate, a monoclonal antibody affinity purified factor VIIi preparation Thrombosis and Haemostasis 63(3): 386-391
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Girma, J.P.; Pietu, G.; Lavergne, J.M.; Meyer, D.; Larrieu, M.J. 1982: Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease Journal of Laboratory and Clinical Medicine 99(4): 481-494
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Meyer, D.; Obert, B.; Pietu, G.; Lavergne, J.M.; Zimmerman, T.S. 1980: Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease Journal of Laboratory and Clinical Medicine 95(4): 590-602
Kessler, C.; Lusher, J.; Pierce, G.F.; Pierce, B.; Koerper, M.A.; Dickinson, J.C. 1995: Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIIi concentrate Lancet 346(8985): 1297-1298
Travis, P.A.; Bovill, E.G.; Hamill, B.; Tindle, B.H. 1988: Detection of factor VIIi von Willebrand factor in endothelial cells in first-trimester fetuses Archives of Pathology and Laboratory Medicine 112(1): 40-42
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Zimmerman, T.S. 1988: Purification of factor VIIi by monoclonal antibody affinity chromatography Seminars in Hematology 25(2 Suppl 1: 25-26
Coppola, R.; Guerra, L.; Ruggeri, Z.M.; Tarantino, A.; Mannucci, P.M.; Ponticelli, C. 1981: Factor VIII/von Willebrand factor in glomerular nephropathies Clinical Nephrology 16(5): 217-222
Teitel, J.M.; Lau, H.K.; Garvey, M.B. 2002: Discrepancies in measured factor VIIi activity in patients treated with factor VIIi concentrate of human or porcine origin Thrombosis and Haemostasis 88(1): 159-160
Sugihara, T.; Saito, H. 1987: Application of a monoclonal antibody against factor XIi (Hageman factor); enzyme-linked immunosorbent assay (ELISA) for factor XIi antigen Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 50(3): 691-695
Kim, H.C.; McMillan, C.W.; White, G.C.; Bergman, G.E.; Saidi, P. 1990: Clinical experience of a new monoclonal antibody purified factor IX: half-life, recovery, and safety in patients with hemophilia B Seminars in Hematology 27(2 Suppl. 2): 30-35
Lane, J.L.; Ekert, H.; Vafiadis, A. 1979: Affinity chromatography of human factor VIII using human and rabbit antibodies to Factor VIII Thrombosis and Haemostasis 42(4): 1306-1315
Rotblat, F.; Goodall, A.H.; O'Brien, D.P.; Rawlings, E.; Middleton, S.; Tuddenham, E.G. 1983: Monoclonal antibodies to human procoagulant factor VIIi Journal of Laboratory and Clinical Medicine 101(5): 736-746